- Country: USA
- Summary: Smallpox Antiviral
- UST Ref No: 71501325
- Deadline: 09 Oct 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75A50122C00047
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The scope of work for this contract (across the Base and Option periods)includes the manufacture and delivery of up to 1.7 Million Treatment Courses (TCs) of the smallpoxantiviral TEMBEXA, comprising oral tablets and oral suspension formulation to the SNS and theassociated activities. - Documents:
75A50122C00047-JA-Other-Than-Full-and-Open-CompetitionRedacted.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSmallpox Antiviral - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Smallpox Antiviral. This tender is published on USARFP under UST Ref No: 71501325 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-10-09.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
